[Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability

• Authors:
  • Minghui Zhang
  • Donye Dominguez
  • Siqi Chen
  • Jie Fan
  • Lei Qin
  • Alan Long
  • Xia Li
  • Yi Zhang
  • Huirong Shi
  • Bin Zhang

• View Affiliations

  
  Affiliations: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Robert H. Lurie Comprehensive Cancer Center, Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA, Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
• Published online on: May 21, 2018     https://doi.org/10.3892/ol.2018.8757
• Pages: 1366-1366

• Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article